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1 Musculoskeletal tissues
Musculoskeletal tissues are a complex system which provides form, 
support, stability, and movement to the body. It is also characterized by 
natural mechano-responsiveness and an efficient complementarity among 
muscles, tendons, ligaments, cartilage, and bones necessary for function 
and coordinated actions both for daily life and the most demanding sports 
activities. The musculoskeletal system relies on the proper articulation of 
soft and hard tissues tailored to accomplish specific functions (Fig. 3.1).
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Skeletal muscles function to produce force and motion and are respon-
sible not only for the articulated movements that allow the locomotion 
but also for the movement of internal organs and protection to external 
shocks. Tendons in the extremities of muscles transmit forces to bones 
while ligaments keep the stability of the joints and movements between 
bones. Bones provide structural support, locomotion, and protection of 
the internal organs as well as in the maintenance of acid-base balance, and 
calcium, magnesium, and phosphate homeostasis [1]. In joints, the end 
of the long bones is covered by cartilage, which protects the bones from 
friction and absorbs the forces over the skeleton. All these tissues work 
together in continuous adjustment to balance the body during locomotion 
and movements.
With the increase in life expectancy and the maintenance of an ac-
tive lifestyle by the aging population, the cumulative musculoskeletal 
FIG.  3.1 Musculoskeletal system. Representation of the structural organization of the 
musculoskeletal tissues and summary of their specific features.
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 conditions potentiate disability throughout life. Although the patholog-
ical conditions result from a combination of genetic, physiological, envi-
ronmental, and behavioral factors, aging and the degeneration of tissues 
and organs have a major impact in increased pain, reduced mobility, and 
lack of patient’s autonomy. Thus, it is imperative to understand the struc-
tural characteristics and physiological behavior of the tissues to develop 
improved tissue engineering and regenerative strategies in order to obtain 
better therapies.
1.1 Physiology and function
1.1.1 Bone
Bones are mineralized connective tissues that compose the skeleton 
of vertebrates, harboring the bone marrow which is the primary site of 
hematopoiesis. The extracellular (ECM) bone matrix is composed of an 
organic (40%) and an inorganic (60%) phase [1]. The organic matrix is 
mainly composed of collagenous proteins, predominantly type I collagen, 
noncollagenous proteins and growth factors [2]. Among the noncollage-
nous proteins, the osteocalcin, osteonectin, and osteopontin are the most 
abundant. Osteocalcin is associated with the regulation of the osteoclasts 
activities and is regarded as a marker of bone formation [3, 4], while os-
teonectin is related to the osteoblast growth and proliferation, and matrix 
mineralization [4]. The matrix cohesion and adhesion of bone tissues is 
maintained by osteopontin [5]. Growth factors and cytokines including 
insulin-like growth factors (IGFs), transforming growth factor β (TGF-β), 
bone morphogenetic proteins (BMPs), fibroblast growth factor (FGF), and 
platelet-derived growth factor (PDGF) are also present in the organic ma-
trix in trace quantities, and modulate cell response to bone remodeling [6]. 
The organic phase forms a fibrillary matrix over which the mineral phase 
nucleates. The inorganic material of bone consists predominantly of crys-
tals of a very insoluble calcium phosphate (CaP) salt, the hydroxyapatite 
[Ca10(PO4)6(OH)2] which is responsible for bone stiffness and load- bearing 
properties. Significant amounts of bicarbonate, sodium, potassium,  citrate, 
magnesium, carbonate, fluorite, zinc, barium, and strontium are also pres-
ent in bone mineral phase [7].
Morphologically, the bone can be classified into the cortical or trabec-
ular bone. Cortical bone is dense and solid and surrounds the marrow 
space, whereas trabecular bone is composed of a honeycomb-like network 
of trabecular plates and rods interspersed in the bone marrow compart-
ment. Regarding the shape and size, bones are classified into four cate-
gories: (1) the long bones, including the clavicles, humeri and femurs; (2) 
the short bones, including the carpal and tarsal bones; (3) the flat bones, 
including the skull, mandible, and scapulae; and lastly, (4) the irregular 
bones which include the vertebrae, sacrum, and coccyx [7].
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The bone cells are the living elements responsible for bone homeosta-
sis and response to external stimuli and comprise osteoblasts, osteocytes, 
bone lining cells, and osteoclasts. Osteoblasts, osteocytes, and bone lining 
cells derive from mesenchymal lineage while osteoclasts are originated 
from the hematopoietic lineage [1]. Osteoblasts are responsible for the 
production of the bone matrix constituents [3]. Conversely, the osteoclasts 
are responsible for bone matrix resorption [4]. Bone health depends on the 
coordination between the resorption activity promoted by the osteoclasts 
and the new-bone deposition promoted by the osteoblasts in a process 
termed remodeling. The osteocytes are terminally differentiated osteoblasts 
that reside within the bone matrix. These are the most abundant bone cells 
and, among other functions, are responsible for the mechanotransduction 
events that allow the bone to adapt to mechanical stress [8]. Bone lining 
cells are mainly metabolically inactive osteoblasts and form the perios-
teum and endosteum. Besides participating in the osteoclast differentia-
tion [2], the bone lining cells contribute to the exchange of ions between 
bones and the surrounding tissues [9].
1.1.2 Cartilage
Cartilage is a highly specialized connective tissue composed of a single 
cell type, the chondrocyte, organized into groups of few cells within an 
ECM rich in collagen fibrils and proteoglycans. Three types of cartilage 
have been identified: fibrocartilage, articular, and elastic cartilage, differ-
ing in the amounts and organization of collagen and proteoglycan and in 
function. Fibrocartilage is found for instance at tendon/ligament junction 
with bone and is designed to stand compressive strength while the prin-
cipal function of hyaline cartilage, often designed as articular cartilage 
available at the surface of diarthrodial joints, is to provide a smooth, lu-
bricated surface for articulation and to facilitate the transmission of loads 
with a low frictional coefficient [10]. The ECM of elastic cartilage found in 
the trachea and ears is also rich in elastin fibers, which allows tolerating re-
petitive deformation. Compared to other connective tissues, cartilage has 
a very slow turnover and a limited capacity to undergo intrinsic healing. 
Hyaline cartilage is the most prevalent type of cartilage. Since cartilage is 
avascular and aneural, nutrition to chondrocytes is provided through dif-
fusion, which is assisted by the fluid flow generated in the compression of 
the articular cartilage or in the flexion of the elastic cartilage.
Articular cartilage comprises four zones. A superficial zone populated 
with a considerable high number of chondrocytes and where collagen fibers 
(primarily, type II and IX collagen) are packed tightly and aligned parallel to 
the articular surface. This zone is in contact with synovial fluid and is respon-
sible for most of the tensile properties of cartilage, which enable it to resist 
the sheer, tensile, and compressive forces imposed by articulation [10]. Then, 
a middle zone constituted with collagen organized obliquely into thicker 
 1 Musculoskeletal tissues 77
collagen fibrils with a low density of spherical chondrocytes. Functionally, 
the middle zone is the first line of resistance to compressive forces [10]. The 
deep zone is responsible for providing the greatest resistance to compressive 
forces, given the high proteoglycan content. The chondrocytes are typically 
arranged in columnar orientation, parallel to the collagen fibers and perpen-
dicular to the joint line [10]. The tide mark distinguishes the deep zone from 
the calcified cartilage. The calcified layer plays an integral role in securing 
the cartilage to bone, by anchoring the collagen fibrils of the deep zone to 
subchondral bone. In this zone, the cell population is scarce and chondro-
cytes are hypertrophic [10]. The anisotropic nature and unique viscoelastic 
properties of cartilage in a structure of few millimeters thick highlights the 
challenges involved in the development of an artificial biomimetic and bio-
functional cartilage substitute for regenerative medicine strategies.
1.1.3 Tendon
Tendons and ligaments are similar dense fibrous connective tissues that 
connect muscle to the skeletal elements (bone) and bone to bone, respec-
tively [11]. These tissues are characterized by the presence of few and dis-
persed fibroblasts/fibrocytes (ligament) or tenoblasts/tenocytes (tendon) 
within a collagen-rich ECM, resulting in a dense and hypocellular structure 
[11]. Tendon ECM is formed from the continual aggregation of the small-
est structural unit, collagen, into an increasingly complex architecture [12]. 
Spontaneous aggregation of multiple collagen molecules results in the for-
mation of collagen fibrils and, in turn, bundles of fibrils form larger primary 
fiber bundles called fascicles, groups of which associate to form tertiary fi-
ber bundles [12, 13]. These are bound together by a thin layer of connective 
tissue named endotenon that contains blood vessels, lymphatics, and nerves. 
The multiple fiber bundles and endotenon are encompassed by the epitenon, 
which is covered by another layer of connective tissue called paratenon.
Tendon tissues are crucial in all joint movements and the limitations of 
current surgical interventions motivate tissue engineering approaches to 
build patient-personalized biological substitutes for tendon repair. Despite 
tendon’s hypocellular nature, different cells co-exist constituting a hetero-
geneous population of tenocytes and tendon stem and progenitor cells [14, 
15]. Although the collagen type I is the major component, tendon ECM also 
includes elastin fibers embedded in a hydrated proteoglycan matrix. The 
collagen fibers resist to tension forces applied to these tissues, while proteo-
glycans are responsible for the viscoelastic properties of tendons [16].
1.2 Response to injury and healing mechanisms
The proportion of the population reporting musculoskeletal conditions 
increased from 28.0% in 1996–98 to 33.2% in 2009–11. The reality of these 
figures is only for the US population, suggesting that these figures can be 
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significantly aggravated [17]. This implies that persons with musculoskeletal 
conditions accounted for an aggregate economic impact of $367.1 billion in 
1996–98 and $796.3 billion in 2009–11, an increase of 117% in real terms [17].
The mechanical forces applied to these tissues can be both protec-
tive and detrimental. Although the mechanical stress is critical for the 
 physio-anatomy of healthy tissues, misuse or overuse can inflict patho-
logical alterations in biomolecular and cell-mediated mechanisms, thus 
contributing to impaired healing.
The healing response of musculoskeletal tissues typically involves an 
acute inflammatory response with the production and release of several 
important molecules including cytokines that initiate a healing cascade. 
In bone, this response is accompanied by the recruitment of mesenchymal 
stem cells (MSCs) in order to generate a cartilaginous callus that undergoes 
mineralization and resorption. The callus provides biomechanical stability 
but requires further remodeling to fully restore the biomechanical proper-
ties of normal bone. The healing of bone fractures is a complex and efficient 
process that occurs without the development of a fibrous scar. Unlike bones, 
damaged articular cartilage and injured tendon/ligaments have limited 
intrinsic healing, likely because of the hypocellular nature and the lack of 
resident vascular and lymphatic vessels that restricts the access to cells and 
biochemical factors with regenerative action. Moreover, in adult tissues, 
mature chondrocytes and tenocytes that are responsible for ECM mainte-
nance, have low mitotic and metabolic rates. In general, early-stage lesions 
in cartilage and tendon are asymptomatic which may relate to the absence 
of an intrinsic nerve network in these tissues. Moreover, these lesions are 
still manageable with antiinflammatory and analgesic drugs. When the 
damage is severe, patients become candidates for surgical interventions, in 
many cases resourcing to tissue grafts, with variable and often insufficient 
outcomes in the long term. The dissimilar healing responses of musculo-
skeletal tissues are thus related to their intrinsic properties and function, 
influencing tissue adaptation and response to mechanical forces (Fig. 3.2).
Impaired tissue restoration or nonresolved healing favors the progres-
sion of lesions into chronic and degenerative conditions, and  compromises 
nearby tissues that can culminate into a total joint destruction. Current 
strategies for the repair of defects and lesions in musculoskeletal tissues 
are generally unsatisfactory as the restored tissue does not meet the me-
chanical biofunctionalities of uninjured tissues.
2 Cartilage regeneration
Cartilage lesions progress from asymptomatic lesions to injuries and 
diseases such as osteoarthritis (OA) that compromise the entire articular 
joint. Cartilage injuries are broadly classified as partial thickness or full 
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thickness defects. Partial thickness (chondral) defects as clefts and fissures 
do not reach subchondral bone and fail to heal spontaneously, while full 
thickness (osteochondral) defects penetrate to the subchondral bone with 
a resource to the blood supply and progenitor cells and elicit of an intrinsic 
repair response. However, the fibrocartilaginous repair tissue formed fails 
to replace hyaline cartilage in organization and function. Current stan-
dard procedures for the treatment of cartilage defects include chondral 
resurfacing with abrasion, debridement, autologous chondrocyte implan-
tation, and matrix-induced chondrocyte implantation, or osteochondral 
autologous transplantation. Cartilage surgical procedures can result in 
short- and mid-term clinical improvement of the joint but do not prevent 
degeneration of repaired tissue and are a major cause of morbidity of do-
nor tissues, interfering with local biomechanics, and creating the need for 
replacement of donor cartilage in future years. Thus, the limited success of 
current treatments and the shortage of cartilage substitutes challenges for 
innovative approaches to improve cartilage treatments and favor tissue 
regeneration.
FIG. 3.2 Schematic representation of the articulation of the musculoskeletal tissues from 
cell to the joint level in the adaptation and response to external mechanical forces.
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2.1 Scaffold/hydrogel-based approaches
During the last decades, hydrogels have been pursued as preferential 
candidates for cartilage tissue engineering and regenerative medicine 
(TERM) approaches. Hydrogels are hydrophilic networks formed by 
physical and/or chemical crosslinking of polymers providing versatile 
and highly desirable 3D environments for biological processes (Table 3.1).
Hydrogels proposed for cartilage approaches have been designed 
with different shapes, complexity (e.g., single and multiple polymers 
and single and multiple crosslinked networks), and tunable properties 
(e.g., mechanical properties and responsiveness toward an external 
stimuli) to support and stimulate cells within a physical matrix [18, 19]. 
These hydrogels have been developed to act as cell carriers [20] and 
other therapeutic agents and to study chondrogenesis and associated 
mechanisms [18, 19]. In large defects, a supportive (hydrogel) matrix 
may assist the transport of therapeutic cells and enhance tissue regen-
eration [21] toward a complete integration with surrounding tissues. 
Furthermore, hydrogels offer the possibility for filling irregular defects 
using minimally invasive procedures for local and sustained delivery 
of therapeutics, including cells, drugs, and bioactive molecules such as 
growth factors and genetic material (revised by Liu et al. [22]) holding 
the promise for off-the-shelf products to use upon request in patient 
customized solutions [23].
The advent of personalized medicine brought the attention for bio-
printing and plotting technologies to hydrogel fabrication. In the partic-
ular case of cartilage, the 3D layered deposition by printing technologies 
can recreate the tissue-specific anatomic-physiological design in shape 
and depth-dependent structure with zonal-like hierarchies assisting the 
fabrication of cartilage constructs with increased biomimicry. Cell-laden 
printing is thought to significantly enhance the interaction between cells 
and matrix and improve tissue regeneration. This technology has been ex-
plored using different cell types and materials; however, the translation of 
knowledge from traditional hydrogel fabrication into these inspirational 
technologies is hampered by the requirement for specific hydrogel prop-
erties. Besides a controlled gelation time and swelling or contraction, bio-
inks require stability and shear-thinning properties to allow their syringe 
uptake and application as well as self-healing features for a fast reassemble 
when shear forces are removed. Bioinks are often chosen for their print-
ability but is also important to consider their influence in the biological 
response. In a study by Daly et al. the phenotype of bone marrow-derived 
mesenchymal stem cells (BM-MSCs) encapsulated in bioinks produced 
with different materials [agarose, alginate, gelatin (GelMA), and BioINK] 
resulted in the development of cartilaginous-like tissues with hyaline-like 
and fibrocartilage-like structures [24].
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Besides the 3D matrix support and stimulation, printing technologies 
are evolving into more complex and multifactorial systems to meet the 
natural requirements of tissues and guide the process of regeneration. Zhu 
et al. investigated the chondrogenic potential of human BM-MSC laden in 
a stereolithography-based 3D bioprinting matrix fabricated with gelatin 
and polyethylene glycol diacrylate (PEGDA) [25] incorporating core-shell 
nanospheres as TGF-β1 carriers. The developed system allowed maintain-
ing cell viability and TGF-β1 bioactivity postprinting. Moreover, TGF-β1 
improved the chondrogenic differentiation of MSCs with increased ex-
pression levels of Collagen II, SOX-9, and Aggrecan.
In a proof of concept work, distinct cell types associated to cartilage 
tissue, namely articular cartilage-resident chondroprogenitor cells, BM-
MSCs, and chondrocytes, were cultured in gelatin-based hydrogels using 
multicompartment printed hydrogels to recapitulate the zonal strati-
fication of native cartilage and assess for preferential zonal-like and for 
cartilage regenerative potential [26]. Despite variations found in the 
amount and quality of cartilage ECM synthetized by the different bioinks, 
this study proposes a bioprinted model for the exploitation of cell-cell 
and cell-matrix interactions within the layered distribution for cartilage 
regeneration.
2.2 Cell-based approaches using mesenchymal stem cells
MSCs potential for cell-based therapies aiming at cartilage regenera-
tion has been anticipated by numerous studies with different models [18, 
21]. Clinical trials aiming at articular cartilage repair, especially focusing 
on the treatment of OA are still at early stages with preliminary aims to 
evaluate safety, feasibility, and efficacy (revised by Lee et al. [27]). Overall, 
these trials indicate pain relief but the renewal or improvement of carti-
lage tissue shows high degree of variability in human subjects. Recently, 
intraarticular administration of autologous human BM-MSC entered 
clinical trials as a safe and feasible procedure with improved outcomes 
for knee OA [28–30]. Autologous peripheral blood stem cells (AAPBSCs) 
were also investigated for the treatment of early OA. Three groups of 20 
patients were 3 weekly treated with APPBSCs activated with platelet-rich 
plasma, with or without granulocyte colony-stimulating factor + IA-HA 
(intraarticular hyaluronic acid carrier) and IA-HA alone (control). Clinical 
scores showed statistically significant improvements at 6 and 12 months 
for the AAPBSC groups vs controls. Moreover, the differential effects of 
stimulated AAPBSCs were noted with an earlier onset of symptom allevi-
ation throughout. At 12 months follow-up, AAPBSC groups also avoided 
the need for total knee arthroplasty [31].
The delivery of MSC to the injury site with a carrier system is an 
 important procedure in clinical therapies to avoid cell leakage to other 
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areas of the joint keeping the therapeutic potential of implanted biological 
agents where it is needed the most. Recent studies showed the success of 
magnetic targeting to deliver MSC system for the treatment of focal artic-
ular cartilage defects [32, 33], including a preliminary study with human 
induced pluripotent stem cells magnetically delivered to osteochondral 
defects in a rat femur model. The latter demonstrated that magnetic forces 
generated by a neodymium magnet improved the repair of the defects 
resulting in the formation of hyaline-like cartilage in comparison to non-
magnetic actuated models [20]. Interesting though is the fact that only 
when external magnetic forces were applied, the tumor formation (tera-
toma) was prevented [20].
In the clinical scenario, a significant improvement was found in the 
outcome scores of the knee defects in 5 human patients 48 weeks after 
magnetic delivery of autologous BM-MSC [33], suggesting the safety and 
efficacy of magnetic targeting as a minimally invasive treatment for carti-
lage repair.
Magnetic actuation strategies also allow for more sophisticated 
 real-time monitoring of the implanted systems while assisting a remote 
noninvasive control of therapeutic agents during follow up treatments. 
The ability to monitoring and control the evolution of tissue regeneration 
contributes to the possibility for medical intervention at critical stages of 
the treatment, thus, assisting better outcomes for the patients.
2.2.1 Cell-free therapies
Increasing evidence suggests that the therapeutic efficacy of MSC relies on 
the paracrine signaling necessary to guarantee proper coordination among 
cells and to modulate the microenvironment surrounding the cells (revised 
by [34]). The trophic role of MSCs for cartilage repair was highlighted by 
Pleumeekers et al. [35] with a coculture of BM-MSC and OA chondrocytes. 
In this work, the extracellular vesicles (EVs) secreted by MSC showed an an-
tiinflammatory effect on TNF-alpha-stimulated OA chondrocytes, inducing 
the stimulated OA chondrocytes to produce ECM. EVs and exosomes are 
part of the cell-to-cell communication and may provide novel opportunities 
as noninvasive tissue-oriented products of regenerative medicine. Toh et al. 
also reported that MSC exosome-treated rats displayed accelerated neotis-
sue filling and enhanced matrix synthesis of type II collagen and sulfated 
glycosaminoglycan (s-GAGs) displaying features that resemble hyaline car-
tilage [36]. In another study performed in a rodent osteochondral model, 
human embryonic MSC exosome-treated animals revealed enhanced tissue 
repair at 2 weeks that persisted and extended to week 12 [37]. At 6 weeks, 
exosome-treated defects showed improved surface regularity and integra-
tion with the host cartilage, hyaline cartilage formation with chondrocytic 
cells, high expression of s-GAG and type II collagen, and low expression of 
type I collagen [37].
84 3. Musculoskeletal tissue engineering approaches
Vonk et al. also investigated the role of EVs secreted by human BM-MSC 
in human OA cartilage repair [38]. EVs inhibited TNF-alpha-induced in-
flammatory effects associated to NF-κB signaling in chondrocytes derived 
from osteoarthritic patients but favored the production of proteoglycan 
and collagen II, thus evidencing important regenerative and immunoreg-
ulatory properties for the regeneration of OA cartilage [38].
The exploratory findings of these vesicles in cell biology and tissue ho-
meostasis and disease models envision ready-to-use exosomal therapies 
translation to human patients. EVs and exosomes are acellular products 
and do not hold the ethical restrictions of a cell-based therapy. Despite the 
minimal risk of immunogenicity and toxicity as a result from their MSC 
origin, exosomes and EVs face some concerns on biosafety, efficacy, kinet-
ics, and bio-distribution and clearance that require investigation in future 
randomized trials.
3 Strategies for bone regeneration
The bone tissue is highly dynamic, responding to mechanical stimuli 
and displaying a remarkable regenerative potential. However, bone de-
fects beyond a critical size, pathological conditions, such as osteogenesis 
imperfecta, osteoporosis, or autoimmune diseases, and glucocorticoids 
compromise bone regenerative ability. Moreover, the healing process is 
not similar for all types of bone, nor follows the same healing fashion. The 
healing of a long bone defect is generally faster than that of flat bone by 
approximately twofolds [39]. Unlike the flat bones, the long bone defects 
undergo endochondral regeneration, recapitulating their embryogenesis 
[39]. Bone-related diseases or bone loss have usually significant effects on 
a patient’s quality of life. The worldwide incidence of bone disorders and 
conditions has trended steeply upward and is expected to double by 2020, 
especially in populations where aging is coupled with increased obesity 
and poor physical activity.
The ultimate goal of bone regeneration strategies is to provide reliable 
cost-effective substitutes to autologous bone grafts, the current gold stan-
dard treatment of large bone lesions. These substitute biomaterials aim to 
reproduce the osteogenic properties of bone grafts, while circumventing 
their associated drawbacks, such as limited availability and requirement 
for secondary surgery [40].
3.1 Bioinspired materials for bone tissue engineering
In order to mimic bone structure and function, the proper control of 
micro-architecture, mechanical properties, and degradability of the scaf-
folds/substrates is of utmost relevance to achieve bone regeneration 
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(Fig.  3.3A) [48]. For instance, the scaffolds for bone TE should provide 
an interconnected micro- and macro-porosity (<10 and >100 μm, respec-
tively) for nutrient diffusion and new bone ingrowth [49]. Moreover, the 
stiffness of the substrates can determine cell fate [50], therefore, the stiff-
ness of the scaffolds should resemble that of natural bone. Finally, bioma-
terials for bone TE approaches should maintain shape stability during the 
healing/regeneration process, in order to promote the formation of the 
anticipated bone volume and not to lose the bridging effect between bone 
margins. Different biomaterial-based approaches have shown potential to 
support bone TE; the use of soft (injectable) polymer-based materials that 
resemble the bone ECM, and the use of stiff scaffolds that mimic the bone 
mechanical support or a combination of both approaches.
FIG. 3.3 Biomimetic bone tissue engineering strategies: (A) micro-computed tomography 
(micro-CT) and histological sections images of trabecular bone [41]. Injectable biomateri-
als: (B) micro-CT images of injectable CaP and hyaluronic acid microparticles loaded with 
platelet lysate nanocomposite cement [42]; (C) histological sections from the reconstructed 
bone using an injectable alginate/hyaluronic acid hydrogel loaded with BMP2 [43]. Scaffold-
based approaches: (D) biofabrication of mandible bone using PCL and cell-laden hydrogels 
[44]; (E) micro-CT and SEM images of an ultra-porous TiO2 scaffold [45]; (F) scanning elec-
tron microscope images of collagen/HAp scaffolds derived from marine sources produced 
using freeze-drying [46]; and (G) digital representation of a human femur and the 3D printed 
hyperelastic-bone (PCL and HAp) [47]. All figures reproduced with permission from the 
copyright holders.
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3.1.1 Injectable bone substitutes
The injectable biomaterials, capable of setting or crosslinking in situ, 
have been explored as bone substitutes. Their ability to be injected into 
complex defects and reshaped to the original bone anatomy before set-
ting is a major advantage over the precasted bone fillers. Therefore, 
these systems are of particular interest to reduce bone fractures or the 
filling of bone defects caused by trauma or neoplasia [51]. The inject-
able calcium phosphate (CaP) cements (CPC) or CaP/polymer com-
posites have found wide applications in bone repair or bone implant 
fixation [51, 52]. The injectable CPCs have been preferred over the CaP/
polymer composites [e.g., polymethyl methacrylate (PMMA)] given 
their milder curing temperatures, which reduce the local site necrosis 
[52]. Injectable CPCs are often a two-component system composed by 
a solid and a liquid phase which, after being mixed, form a self-setting 
paste. The solid phase usually contains hydroxyapatite and other cal-
cium salts that can originate apatite or brushite cement, depending on 
the original composition, the first being more soluble than the second 
(more information in [52]). The similarity with bone mineral matrix 
composition makes the injectable CPCs highly biocompatible and oste-
oinductive. Moreover, their compressive strength, ranging from 0.2 to 
180 MPa [53], spans that of human trabecular (4–12 MPa) and cortical 
bone (130–180 MPa) [54].
For filling of bone fractures, or implant fixation [51] the injectable CPCs 
are good alternatives to bone grafts. Nevertheless, the low bioresorb-
ability and bone ingrowth rates of the injectable CPCs or the polymeric 
bone cement impair their application for the regeneration of large bone 
defects. The incorporation of micro- and macro-porosity has been success-
fully attempted for accelerating the degradation of injectable cement [42] 
and improving bone tissue ingrowth and osteointegration of the cement. 
Moreover, the porogenic elements can be used as growth factors’ delivery 
vehicles [42, 55]. In a recent work, Babo and coworkers incorporated plate-
let lysate (PL) into injectable CPCs, both directly into the cement paste or 
laden in hyaluronic acid (HA) microparticles [42] (Fig. 3.3B). The incor-
poration of platelet-rich hemoderivatives, namely PL, into regenerative 
medicine approaches intends to benefit from their richness in cytokines 
and growth factors involved in the orchestration of wound healing [56]. 
The incorporation of PL directly into the cement paste or laden into HA 
microparticles was shown to modulate the release of specific growth fac-
tors and, consequently, the osteogenic potential of the injectable CPCs 
composites [42]. Conversely, the increase of the porosity makes the cement 
brittle and decreases the load-bearing capacity [42, 53]. The low stability 
of these cement composites compromise their therapeutic potential, par-
ticularly for flat bone regeneration [57–59].
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Produced by the crosslinking of natural or synthetic polymers, the mesh 
of the injectable hydrogels closely mimics the ECM of connective tissues. 
Moreover, the mild conditions used to crosslink the hydrogels and the aque-
ous environment, allow for the loading and sustained release of biomole-
cules and cell encapsulation [43, 60, 61]. Jung and coworkers proposed a 
hybrid hydrogel composed of the natural origin polymers alginate and HA, 
which gelled in situ with Ca2+, for the delivery of the pro-osteogenic BMP-2 
and BM-MSCs [43]. The combined effect of BMP-2 delivery and BM-MSCs 
promoted the regeneration of a mandibular defect in guinea pigs (Fig. 3.3C) 
[43]. Other versatile crosslinking chemistries have been proposed for hy-
drogels production with potential for bone regeneration. In our group, 
methacrylated glucosaminoglycans have been studied for the production 
of PL-laden hydrogels [60, 62, 63]. These PL-laden hydrogels were shown 
to be stable and released growth factors in a sustained manner for long time 
frames [60, 62, 63]. Moreover, the incorporation of PL into HA hydrogels 
enhanced the osteogenic differentiation of human dental pulp stem cells 
[64]. Likewise, synthetic materials have been explored to produce injectable 
hydrogels for the delivery of BMP-2 [65]. Nanoparticles of the thermosensi-
tive poly(phosphazene) were modified with PEG to enhance the affinity of 
BMP-2 [65]. The hydrogels produced by thermal actuation over nanoparti-
cles solutions were able to release BMP-2 up to 3 weeks promoting ectopic 
and orthotopic bone formation in mice [65].
The incorporation of hydroxyapatite nanoparticles into the hydro-
gel matrices, emulating the bone ECM has also been explored [66]. 
Hydroxyapatite nanocomposite hydrogels of silk are more osteoinductive 
and promote larger bone regeneration in preclinical models than the in-
jectable silk hydrogels alone [66].
3.1.2 Scaffold-based approaches
In scaffold-based approaches, the structural characteristics, such as 
roughness, scaffold porosity, pore structure, and interconnectivity, play 
a crucial role to provide optimal conditions for bone tissue formation 
in vitro and in vivo [67]. However, in load-bearing applications, the scaf-
fold is also expected to provide sufficient mechanical support during the 
bone healing process and substitute the lacking mechanical function of 
the missing or damaged bone tissue. In order to retain its pore architec-
tural structure under physiological loading and to support and transfer 
the appropriate mechanical stimulation to the bone forming cells within 
the scaffold and to the host bone, a porous bone scaffold is required to 
exhibit initial mechanical strength and stiffness that is comparable to the 
native bone tissue [68]. Therefore, the ideal scaffold should display good 
mechanical strength, biocompatibility, osteoconductivity, and optimal size 
and interconnected porous spaces for the bone cells homing.
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Natural and synthetic materials, or their combinations, have been in-
vestigated as bone scaffolds (for detailed recent reviews, readers are 
addressed to Ref. [69, 70]). On one hand, natural polymers, such as colla-
gen, chitosan, silk fibroin, and HA, tend to exhibit excellent biomimicry, 
biocompatibility, and biodegradability. These materials are particularly 
suitable to fabricate hydrogels, cryogels, and freeze-dried scaffolds. 
Nevertheless, the scaffolds created using these methods tend to show lim-
ited mechanical properties, which may impair their use in load-bearing 
bone repair. On the other hand, synthetic polymers, such as polycaprolac-
tone (PCL), poly-lactic acid (PLA), and PEG, offer suitable solutions for 
mechanical challenges faced by the natural polymers. These have been 
used to produce bone scaffolds through techniques such as porogen leach-
ing, gas foaming, phase separation, fiber meshing, supercritical fluid pro-
cessing, microsphere sintering, and 3D printing. Yet, synthetic polymers 
are characterized by poorer cell attachment properties and slower degra-
dation rates.
Blending of natural and synthetic polymers has offered suitable solu-
tions for the shortcomings of both types of polymers. For example, our 
group developed blends of starch and PCL or PLA to produce fiber-mesh 
scaffolds with adequate porosity and mechanical properties to support 
cell adhesion, proliferation, and differentiation into the osteoblast lineage 
in vitro and bone formation in vivo [71–74]. In a biofabrication approach, 
Atala’s Group combined the mechanical integrity of PCL with the superior 
biological performance of cell-laden gelatin/fibrinogen/HA hydrogels to 
create perfusable constructs using a multihead 3D printer (Fig. 3.3D) [44]. 
The authors showed the feasibility to produce clinical-relevant size con-
structs matured into vascularized functional tissues assessed in mandible, 
calvarial bone, cartilage, and skeletal defects in rodents.
Ceramic scaffolds are typically derived from biocompatible and os-
teoconductive inorganic materials, such as CaPs, bioglass, and titanium 
oxide (TiO2). The chemical composition of CaPs, such as hydroxyapatite 
(HAp) and tricalcium phosphate (TCP), is close to the inorganic phase 
of bone, which makes these materials very attractive for bone scaffolds. 
In this regard, nearly 60% of the commercially available synthetic bone 
graft substitutes involve ceramic materials [75]. Porous ceramic scaffolds 
have been classically produced by different methods including bone de-
cellularization, sponge replication, and gas foaming. Furthermore, two 
recent studies have explored the possibility of 3D print ceramic-based 
materials (TCP and HAp) [76, 77]. These ceramic inks allowed rapid man-
ufacturing of scaffolds with micro- and macroporosity needed for bone 
regeneration. Using a biocompatible and bioactive material, Haugen and 
colleagues developed bone biomimetic ultraporous TiO2 scaffolds with 
compressive strength above 2.5 MPa using the foam replication process 
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(Fig.  3.3E). These scaffolds promoted osteogenic differentiation in  vi-
tro and bone formation using different in vivo models [45, 78–80]. Our 
group has been working with marine species such as coral skeletons, sea 
urchins, and sponges as biomorphic scaffolds and templates for bone TE, 
since they represent a promising, inexpensive, and biomimetic alternative 
to engineered scaffolds [81, 82]. In particular, sponges interconnected po-
rous architecture together with their high content in biosilica have been 
shown to mimic ideal bone scaffolds and to stimulate bone formation and 
mineralization [83].
Although ceramic scaffolds might present a biomimetic architecture 
while exhibiting high stiffness and compressive strength, there is some 
concern regarding the brittle nature of these materials. Creating compos-
ite materials addresses the challenges experienced by single material and 
has yielded more optimal materials and functionalized scaffolds [69]. 
Generally, ceramic and bioglass minerals are added to the natural and 
synthetic polymers to create scaffolds with enhanced mechanical and 
biological performance. While the presence of CaP-based ceramics in 
the composites improves compressive strength, degradability rate, and 
osteogenic capacity of the scaffold, the polymers are credited for main-
taining good elastic strength and providing a crosslinking mechanism. 
Composites such as TCP/polymer, PLA/CaP, HAp/starch, HAp/colla-
gen, and PCL/HAp are frequently reported in the literature [69]. Using 
novel biomaterials sources, that is, by-products of the fishing industry 
such as fish skin and bones, collagen/CaP scaffolds produced using 
freeze-drying supported attachment and proliferation of  osteoblast-like 
cells (Fig. 3.3F) [46]. A very interesting and recent composite biomate-
rial for bone regeneration is the hyperelastic “bone,” developed by Jakus 
et al. (90 wt% HAp and 10 wt% PCL) [47]. This material was rapidly 3D 
printed into personalized bone scaffolds with excellent elastic mechan-
ical properties (~32%–67% strain to failure, ~4–11 MPa elastic modulus) 
(Fig.  3.3G). Furthermore, it induced osteogenic differentiation of hu-
man BM-MSCs cultured in vitro without exogenous supplementation of 
 osteo-inducing factors in the medium and supported new bone growth 
in  vivo. More recently, nanocomposites involving biopolymeric matri-
ces and bioactive nanosized fillers have gained a considerable amount 
of attention due to their capacity to mimic the nano-sized features of 
the natural bone mineral [84, 85]. Minardi et  al. fabricated a biologi-
cally inspired nanocrystalline magnesium-doped HAp/collagen type 
I composite scaffold in order to mimic the composition and structure 
of the osteogenic niche [86]. These scaffolds increased the expression 
of osteogenic markers in  vitro, when compared with nonmineralized 
 collagen-based scaffolds, and allowed the formation of trabecular and 
cortical bone in vivo.
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4 Tendon regeneration
Tendons and ligaments hold a critical role in the musculoskeletal sys-
tem, transmitting forces, and stabilizing the joints, being able to withstand 
the high tensile forces upon which locomotion is entirely dependent [16, 
87, 88]. The anatomical location, architecture, and function make these tis-
sues highly prone to injuries with limited endogenous resolution.
The development of engineered functional tendons is greatly depen-
dent on the mimicry of tendon mechanical behavior and structural compo-
nents in order to recapitulate the tendon matrix toward the development 
of functional substitutes. Moreover, the replication of native tendon mi-
croenvironment, requiring a highly aligned architecture and oriented 
cell morphology [89] is a key aspect in biomaterials design. Therefore, 
the challenge to engineer advanced functional biomaterials holding me-
chanical and structural cues highly depends on the proper combination of 
material type, processing technique, and structure design. In terms of me-
chanical properties, tendons exhibit a unique crimp pattern and viscoelas-
tic properties akin to a spring that enables tendon to effectively store and 
subsequently release mechanical energy [90]. The profile of a typical ten-
don stress-strain curve is composed of different regions: at the toe region 
of strain up to 2% the tendon retains a characteristic crimped structure; 
the linear region in which the strain remains lower than 4% and the ten-
don behaves in an elastic fashion being able to lengthen its crimped colla-
gen fibers and withstand forces. The linear region is representative of the 
physiological range of the tendon and the slope of the curve defines the 
Young’s modulus of the tissue. Stretching over 4% results in microscopic 
tearing and tendinopathy can develop, whereas repeated micro-tears and 
strain beyond 8%–10% leads to macroscopic failure and tendon rupture 
[12, 91, 92]. Thus, in order to engineer a tendon mimetic scaffold, the char-
acteristic nonlinear biomechanical behavior of tendons and the character-
istic anisotropic hierarchical structure (as described in Section 1.1) must 
be combined.
4.1 Biomaterial processing technologies to meet tendon 
function and properties
4.1.1 Fiber-based technologies
The complex fibrous hierarchical structure of tendon instigates engi-
neers in the development of materials that ensure enough strength under 
uniaxial tension and, at the same time, viscoelastic properties in order to 
optimize stiffness under different loading environments [93]. A growing 
number of publications resources to aligned scaffolds that can exert influ-
ence on cell morphology and tenogenic differentiation in both in vitro and 
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in vivo models [94–101]. A recent example of the development of aligned 
scaffolds for tendon TE was proposed by Zheng and coworkers [102] in 
which a macroporous 3D aligned collagen/silk scaffold was investigated 
in a rabbit massive rotator cuff tear model. Aligned collagen/silk scaf-
folds were fabricated using 12 yarns of silk fibers and also resourcing to a 
unidirectional freezing technology. These scaffolds presented a profound 
influence on the cellular morphology and arrangement of rabbit ten-
don stem/progenitor cells. Moreover, the in vivo performance revealed 
abundant organized bundles of collagen fibers formed in the outer zone 
of the macroporous 3D aligned collagen/silk scaffold and evidence of a 
denser, matured and organized regenerative tissue with cell infiltration 
[102]. Indeed, aligned fiber-based scaffolds were suggested to guide cell 
response from repair to healing [95]. Lee et al. also evaluated the effect of 
fiber diameter of unaligned meshes and fiber alignment on human tendon 
fibroblast attachment, organization, growth, and phenotype, as models of 
connective tissue repair and healing. Unaligned fibers with nanometer 
diameters promoted cell proliferation and matrix deposition as well as 
the expression and activity of RhoA and Rac1, characteristic of the initial, 
proliferative phase of wound repair. Moreover, the mature repair model 
represented by unaligned micron-sized fibers supported cell organization 
and adhesion, while suppressing cell growth and ECM biosynthesis, in-
dicative of the remodeling phase of tissue repair. The nanofiber model 
showed matrix alignment as a critical design factor for circumventing scar 
formation and promoting biological healing of soft tissue injuries [95].
Conventional fiber fabrication techniques toward the replication of 
tendon structure relied on spinning-based methods, such as wet- and 
melt-spinning [103–105]. In recent years, electrospinning systems have 
been increasingly used for the production of nano- to micro-fibrous 
anisotropically aligned biomaterials from a wide range of polymer ma-
trices (Table 3.2). Electrospinning technique consists of a capillary system 
through which the spinning dope solution to be electrospun is forced, a 
high-voltage source, and a grounded collector [89]. The potential of elec-
trospun nanofiber scaffolds to modulate cells behavior has been exten-
sively reviewed [114–116].
Generally, the produced electrospun fibers are 2D matrices that need to 
be assembled into hierarchical scaffolds to mimic tendon architecture. One 
option that has also been considered in tendon TE is the use of textile tech-
nologies such as knitting, weaving, or braiding [117, 118] for assembling 
fibrous structures into 3D tendon mimetic scaffolds. A recent study by 
Rothrauff et al. provides a representative example of this strategy for ten-
don and ligament TE [108]. Multilayered scaffolds of aligned electrospun 
nanofibers were produced using two designs, stacking or braiding. For 
multilayered scaffold fabrication, the PCL and poly-l-lactic acid (PLLA) 
nanofibrous sheets were either manually stacked or rolled and braided. 
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Braiding technique increased suture-retention and tensile strength, but de-
creased cell infiltration and proliferation compared to stacked constructs. 
Despite this, both multilayered scaffolds supported tenogenic differentia-
tion of seeded MSCs by expression of tenogenic markers [108].
Recently, our group developed aligned nanofibrous scaffolds [106, 107] 
aimed at tendon TE using electrospinning technique. Electrospun nano-
fiber scaffolds combining chitosan (CHT), a natural polymer, and PCL, 
a synthetic polymer, were reinforced with cellulose nanocrystals (CNCs) 
[106], and the electrospinning was conducted using a home built disk 
electrospinning unit. The topography of anisotropically aligned scaffolds, 
as opposed to randomly oriented scaffolds, promoted a remarkable uni-
axial cell orientation and induced elongated tendon cells morphology. 
Moreover, the incorporation CNCs into electrospun natural/synthetic 
polymer (PCL/CHT) nanofiber bundles significantly improved mechan-
ical properties in tendon/ligament relevant range (σ = 39.3 ± 1.9 MPa and 
E = 540.5 ± 83.7 MPa, P < .0001) [106]. Based on this knowledge, we further 
developed continuously aligned nanofiber threads (CANT) based on op-
timized PCL/CHT/CNC formulations and explored their assembly into 
3D scaffolds using different textile techniques, including twisting, braid-
ing, and weaving [107]. Briefly, the spinning solution is jetted to the sur-
face of the supporting liquid bath under the high-voltage electric field and 
the nanofibers formed. CANT, that represent the tendon collagen fibers, 
are taken up by a roller at a constant speed from the surface of the nanofi-
bers supporting liquid bath, resulting in a continuous thread that is then 
twisted into yarns, representing tendon fascicles. In the final fabrication 
step, braiding and weaving textile techniques are used to obtain 3D scaf-
folds replicating tendon macroscale organization composed of fascicle as-
semblies. The deposition of aligned tendon-related ECM components by 
human adipose stem cells (hASCs) suggested that the topography of the 
woven scaffolds may be inducing a tissue-specific behavior comparable to 
native tendon cells [107].
4.1.2 3D bioprinting technologies
Bioprinting has been recently defined as the use of computer-aided 
transfer processes for patterning and assembly of living and nonliving ma-
terials with a prescribed 2D or 3D organization to produce bio-engineered 
structures serving in regenerative medicine, pharmacokinetics, and basic 
cell biology studies [119], and recently reviewed by others [119–123]. The 
material must exhibit steady flow until deposition and must rapidly stabi-
lize upon delivery [123]. Finding the materials formulations for the devel-
opment of bioinks is thus a challenge, even more because it incorporates 
cells which may impact the biomaterial properties during extrusion.
Bioprinting is a field under development and very few studies have been 
published envisioning the fabrication of tendon TE scaffolds. However, in 
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this context, 3D organ printing technology was used by Merceron et al. 
to fabricate a muscle-tendon unit construct [124]. The combination of 
polymeric printing patterns (structural component) with cell-laden bio-
ink patterns (the cellular component) resulted in customizable hybrid 
constructs. Thermoplastic polyurethane (PU) and C2C12 myoblasts were 
used for the muscle side and PCL and NIH/3T3 fibroblasts for the tendon 
side. These constructs showed over 80% cell viability 1 week after print-
ing and the cells self-organized patterns were consistent with the tissue 
interface. Anticipating patient-specific therapies, 3D bio-printed scaffold 
sleeves made of PCL-PLGA-β-TCP were developed as a way of mimicking 
the actual size and shape of the tendon and bone tunnel. Scaffold sleeves 
were seeded with MSCs and tested in an anterior cruciate ligament (ACL) 
reconstruction in a rabbit model for up to 12 weeks [125]. The construct 
exhibited excellent results in osteointegration enhancement between the 
tendon and tunnel bone in the ACL reconstruction [125].
The development of a magnetic scaffold by 3D printing was also de-
scribed by us [96], based on a polymeric blend of starch and PCL (SPCL) 
and the incorporation of magnetic nanoparticles. The purpose was to 
combine structural features of the 3D scaffold with mechanomagnetic ac-
tuation to improve the differentiation of hASCs to the tenogenic pheno-
type and assist tendon regeneration. The scaffolds, with aligned fibers, 
were shown to assist in the tenogenic differentiation of hASCs under 
 magneto-stimulation with evidence of good biocompatibility and integra-
tion in an ectopic rat model [96].
4.2 Current applications and clinical potential
Current treatments for tendon injuries, ranging from acute tendon rup-
ture to chronic degenerative tendinopathy, are conservative or via surgical 
procedures. The first includes the management of pain, using antiinflam-
matory medication, immobilization, physiotherapy, and commercial treat-
ment modalities, for example, ultrasounds or extracorporeal shock waves 
[92, 126]. Surgical treatments are mostly considered as last resort when 
conservative therapy has failed. In these cases, surgeons suture tendon 
ends, with or without resourcing to autografts or allografts to bridge de-
fects in larger ruptures. Autografts are harvested from a different location 
in the body leading to donor site morbidity while the use of allografts 
raises concerns about immune rejection and risks for disease transmission. 
Moreover, commercial biological or synthetic substitutes have been re-
ported in clinical applications. These scaffolds derived from human acellu-
lar tissue GraftJacket [127, 128] or from bovine (TissueMend, OrthoMend, 
and BioBlanket) and porcine dermis (Restore and Zimmer Patch) have a 
rich collagenous matrix and have been used for the reinforcement of soft 
tissues. Examples of synthetic substitutes include Ligament LARS [129], 
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revised by Batty et  al. [130]. On the way to clinical translation, clinical 
trials are being assigned with alternative substitutes, such as amniotic 
fluid-derived allograft (NCT03379324), tendon autografts (NCT03073083; 
NCT03671421), or ArthroFLEX ECM scaffold (NCT03551509). Also, rele-
vant cell-based therapies to address tendon injuries are under evaluation, 
specifically with MSCs (NCT03449082; NCT03362424).
5 Future perspectives and concluding remarks
This chapter presented an overview of biomimetic strategies for the 
regeneration of the different musculoskeletal tissues that show unique 
composition, structure, and function. Nonetheless, these tissues present 
a continuous structure, rather than being independent tissues, which 
results in the formation of complex, composite, and graded junctions 
or interfaces that should also be considered in regenerative approaches. 
One such example is the tendon-to-bone junction, also called enthesis 
that involves the transition from an anisotropic fibrous structure with 
high tensile strength to an isotropic calcified structure optimized for 
compressive loading. Indeed, this interfacial tissue is essential to ensure 
smooth mechanical stress transfer between bone and tendon and to as-
sist the integration of potential tissue substitutes. As another example, 
osteochondral tissues or cartilage-to-bone interfaces contain a fibrous 
superficial zone that transitions from hyaline cartilage to calcified bone. 
Given the complex structure and the central role in force transmission, 
these interfaces are points of high stress concentration and, thus, more 
prone to fail, which can ultimately result in significant physical and 
financial burden. Therefore, the engineering of biomaterials that reca-
pitulate the complex tissue interfaces remains among the most unad-
dressed challenging areas in TERM, demanding for complex integrative 
multimodal approaches.
Another challenge that needs to be addressed is that the oversimplified 
ECM produced by the crosslinking of polymers barely emulates the na-
tive tissue microstructure. The self-organization of organic polymers into 
ordered supramolecular assemblies is common to various systems since 
DNA assembling to collagen fibers elongation. A great interest has been 
shown in the study of self-assembling low-molecular-weight gelators by 
noncovalent interactions as molecular scale building blocks to produce 
biomaterials with defined micro- and nano-architectures and tunable 
physicochemical properties. This technology entangles the advantages of 
the injectable therapeutics with the instructive role of the engineered mi-
croenvironments. The application of this technology to the regenerative 
medicine field can produce therapeutics that may well be administrated 
using minimally invasive procedures, for instance by injection, into a 
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 ruptured tendon, and spontaneously produce aligned fibers bridging the 
collagen fibers from the defect margins.
Technological progress in the field is leading to the development of 
more efficient therapies toward patient-oriented solutions that take into 
account the individual variability of each patient. Nowadays, precision 
or personalized medicine concepts are being utilized by TE researchers 
in the consideration of customized approaches, bearing in mind the heal-
ing potential, lifestyle, and outcome expectations. In this sense, stem cells, 
 biomaterial and stimulation technologies, might be tailored in order to 
meet patient individual requirements. Biofabrication techniques, by which 
one can control geometry and cellular deposition, together with 3D imag-
ing to screen the anatomical shape, can provide a high level of biomimicry 
in the construction of complex tissues and organs substitutes. Another as-
pect is the use of suitable bioactive molecule formulations which can be 
doped into biomaterials for controlled release in spatiotemporal manner, 
according to the specific needs of each defect or treatment. The combina-
tion of biologically inspired signals with materials science and adequate 
cellular sources, either autologous strategies or precommitted prone cells, 
are aspiring approaches that boost precision and personalized concepts in 
TERM toward the future.
The emergent technologies, including 3D bioprinting, molecular im-
printing, and recombinant growth factor delivery have allowed the ac-
cumulated knowledge in pathology genesis, healing processes, and the 
underlying molecular crosstalk. The spatio-temporal control of biochemical 
and mechanical stimuli delivery has been studied with promising results 
[62]. Furthermore, the clinical demands for improving biomaterials inte-
gration and promote a favorable healing response is a major aim of TERM 
strategies. At a biomaterial level, it has been suggested the request to iden-
tify and modulate biomaterials design characteristics to interact with local 
cells, while other approaches follow a more biological role with attempts 
to modulate macrophage polarization due to their pivotal role in healing. It 
is likely that a successful outcome will be achieved from a combination of 
both complemented with immune microenvironment engineering, leading 
to a significant and fast increment in immune-centric approaches in the up-
coming years. Insights on immune system mechanisms and the successful 
interaction and guidance of the physiological cascade toward regeneration 
will anticipate a revolution of medical procedures and healthcare in gen-
eral, opening new avenues for cell, gene, and immune-therapies. In the 
upcoming years, the TERM research lines aiming the regeneration of mus-
culoskeletal tissues are expected to evolve in order to address the specific 
needs of the patients, having into consideration their healing potential, life-
style, and outcome expectations, following a precision medicine paradigm.
Thus, despite all the knowledge gathered in the design and devel-
opment of biomimetic materials to the research on biological processes, 
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 including cellular and tissue responses to the presence of a bioengineered 
tissue/organ, there are still challenges to be overcome toward complete 
integration and regeneration. The combinatorial exploitation of materials 
and architectures to modulate cell responses supported by technological 
advances and innovative approaches will approximate to the complete 
regeneration goal meeting architectural, functional, bio-responsive, and 
personalized therapeutic solutions.
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